Results for tag: "Glucokinase Activator"

The Glucokinase Activator market is a subset of the Endocrine and Metabolic Disorders Drugs market. Glucokinase Activators are drugs used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or is unable to use insulin properly. Glucokinase Activators work by stimulating the production of insulin, which helps to regulate blood sugar levels. They are typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels. Glucokinase Activators are generally well-tolerated and have few side effects. They are available in both oral and injectable forms, and can be used in combination with other diabetes medications. Some companies in the Glucokinase Activator market include Novo Nordisk, Eli Lilly, Merck, and Sanofi. Show Less Read more